Caris Life Sciences Inc
CAI22.000USD
+0.750+3.53%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
6.21BValor de mercado
PerdaP/L TTM
Mais detalhes de Caris Life Sciences Inc Empresa
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Informações de Caris Life Sciences Inc
Código da empresaCAI
Nome da EmpresaCaris Life Sciences Inc
Data de listagemJun 18, 2025
CEOHalbert (David Dean)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 18
Endereço750 W. John Carpenter Freeway
CidadeIRVING
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75039
Telefone18667718946
Sitehttps://www.carislifesciences.com/
Código da empresaCAI
Data de listagemJun 18, 2025
CEOHalbert (David Dean)
Executivos da empresa Caris Life Sciences Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Detalhamento da receita
Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
213.55M
98.49%
International
3.28M
1.51%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: sáb, 31 de jan
Atualizado em: sáb, 31 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
Outro
33.40%
Investidores
Investidores
Proporção
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
Outro
33.40%
Tipos de investidores
Investidores
Proporção
Individual Investor
48.48%
Investment Advisor
21.18%
Hedge Fund
11.06%
Private Equity
10.54%
Investment Advisor/Hedge Fund
5.08%
Pension Fund
0.53%
Research Firm
0.29%
Sovereign Wealth Fund
0.13%
Family Office
0.02%
Outro
2.70%
Participação acionária institucional
Atualizado em: qua, 21 de jan
Atualizado em: qua, 21 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q4
228
134.49M
38.87%
--
2025Q4
258
136.99M
48.55%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Halbert (David D)
122.76M
43.51%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.64%
--
--
Sep 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.18%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.68%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.59%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
9.58M
3.39%
+963.04K
+11.18%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.03M
2.84%
+721.77K
+9.88%
Sep 30, 2025
Braidwell LP
7.32M
2.59%
--
--
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.92M
2.45%
+154.50K
+2.29%
Sep 30, 2025
Silver Lake Partners
5.29M
1.88%
--
--
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
Ver Mais
ARK Genomic Revolution ETF
Proporção0.67%
Texas Capital Texas Small Cap Equity Index ETF
Proporção0.52%
Renaissance IPO ETF
Proporção0.43%
RiverNorth Patriot ETF
Proporção0.3%
Franklin Genomic Advancements ETF
Proporção0.29%
Invesco Russell 1000 Equal Weight ETF
Proporção0.08%
Inspire 500 ETF
Proporção0.07%
T Rowe Price Small-Mid Cap ETF
Proporção0.05%
Texas Capital Texas Equity Index ETF
Proporção0.04%
Fidelity Nasdaq Composite Index ETF
Proporção0.02%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
